Lampaso, Jenelyn L.
HRN: 22-07-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2022
METRONIDAZOLE 500MG (TAB)
10/19/2022
10/26/2022
ORAL
500mg/tab
TID
S/P NSVD; THICKLY MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes